Tag Archives: Kristin Risa

Research: Fitbit trackers & PROMs help monitor ME/CFS activity

Posted on 09/29/2022 by wames

Activity monitoring and patient-reported outcome measures in ME/CFS patients A small Norwegian study from the team led by Prof Olav Mella and Dr Oystein Fluge trialled wearable activity trackers and questionnaires to monitor heart rate and activity to aid pacing … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Research: Fitbit trackers & PROMs help monitor ME/CFS activity

Research: A map of metabolic phenotypes in patients with ME/CFS

Posted on 09/10/2021 by wames

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/ chronic fatigue syndrome by Fredrik Hoel, August Hoel, Ina Kn Pettersen, Ingrid G Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L Thürmer, Merete … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Research: A map of metabolic phenotypes in patients with ME/CFS

Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Posted on 05/04/2020 by wames

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study by Ingrid G Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J Tronstad, Kristin Risa, Kine Alme, Marte K Viken, Benedicte A Lie, Olav … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Intravenous cyclophosphamide in ME/CFS. An open-label phase II study